Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02664961
Title Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Tracon Pharmaceuticals Inc.

trophoblastic neoplasm


Bevacizumab + Carotuximab

Age Groups: adult | child | senior
Covered Countries USA

No variant requirements are available.